BioCentury
ARTICLE | Clinical News

PCI preclinical data

August 24, 2009 7:00 AM UTC

In a mouse model of human non-pigmented melanoma skin cancer, PCI coupled with scFvMEL/rGel significantly slowed tumor growth vs. controls. Specifically, by day 30 all of the mice in the control grou...